The function of Lyn in B cell activation has been studied recently by
examining the properties of B cells from mice in which the lyn gene ha
s been inactivated by gene targeting. These mice show evidence of B ce
ll hyperreactivity in vivo, as the number of B lymphoblastoid cells gr
eatly increase with age, IgM levels increase by IO-fold or more, and a
utoantibodies to double-stranded DNA and other nuclear antigens become
apparent. B cells from lyn(-/-) mice also exhibit enhanced BCR-induce
d activation of MAP kinases, intracellular calcium elevation and proli
ferative responses in vitro. These phenomena may relate to participati
on of Lyn in events that serve to decrease B cell responses to antigen
. Among the leading candidates for these suppressive events are the in
hibition of B cell antigen receptor function by Fc gamma RIIb1 and by
CD22. Although Lyn also participates positively in the initial events
of B cell antigen receptor signal transduction, this function can also
be supplied by other tyrosine kinases, presumably other Src-family ki
nases. In contrast, some aspects of inhibition by CD22 appear to be al
most completely dependent upon Lyn and Fc gamma RIIb1 inhibition is al
so diminished in the absence of Lyn. Thus, the net effect of Lyn actio
n is negative rather than positive for B cell activation.